(BCRX) Biocryst Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Biocryst Pharmaceuticals | (BCRX) share price targets
Complete technical analysis of Biocryst Pharmaceuticals (BCRX) by charts plus indicators, forecast predictions and share price targets for Biocryst Pharmaceuticals (BCRX)
Biocryst Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Biocryst Pharmaceuticals is 2104114
Date | Daily Closing Price | Open | High | Low | Volume |
24 Tue Dec 2024 | 7.67 | 7.73 | 7.84 | 7.60 | 0.358 times |
23 Mon Dec 2024 | 7.78 | 7.57 | 7.81 | 7.38 | 0.724 times |
20 Fri Dec 2024 | 7.57 | 7.25 | 7.59 | 7.25 | 2.283 times |
19 Thu Dec 2024 | 7.39 | 7.34 | 7.48 | 7.22 | 0.948 times |
18 Wed Dec 2024 | 7.31 | 7.47 | 7.59 | 7.15 | 1.1 times |
17 Tue Dec 2024 | 7.49 | 7.23 | 7.62 | 7.23 | 0.736 times |
16 Mon Dec 2024 | 7.46 | 7.41 | 7.54 | 7.20 | 1.238 times |
13 Fri Dec 2024 | 7.53 | 7.56 | 7.63 | 7.43 | 0.759 times |
12 Thu Dec 2024 | 7.60 | 7.83 | 7.88 | 7.58 | 0.684 times |
11 Wed Dec 2024 | 7.86 | 7.90 | 8.07 | 7.82 | 0.686 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 7.7 as stoploss in an intra day sell trade for a target of 7.51. However, stock will show a bullish move above 7.7.
Share price targets for Biocryst Pharmaceuticals (BCRX)
Target Type | Value |
Downside Target | 6.49 |
Downside Target | 6.85 |
Downside Target | 7.01 |
Downside Target | 7.15 |
Downside Target | 7.38 |
Upside Target | 7.84 |
Upside Target | 8.07 |
Upside Target | 8.38 |
Upside Target | 8.44 |
Upside Target | 8.84 |
Upside Target | 8.88 |
Intraday share price targets for Biocryst Pharmaceuticals (BCRX)
Target Type | Value |
Downside Intraday Target | 7.42 |
Downside Intraday Target | 7.17 |
Upside Intraday Target | 7.88 |
Upside Intraday Target | 8.09 |
Downside Intraday Target | 7.63 |
Weekly technical analysis of Biocryst Pharmaceuticals (BCRX)
Date | Weekly Closing Price | Open | High | Low | Volume |
24 Tue Dec 2024 | 7.67 | 7.57 | 7.84 | 7.38 | 0.172 times |
20 Fri Dec 2024 | 7.57 | 7.41 | 7.62 | 7.15 | 1.727 times |
13 Fri Dec 2024 | 7.53 | 7.60 | 8.07 | 7.43 | 5.366 times |
26 Tue Nov 2024 | 7.49 | 7.27 | 7.54 | 7.17 | 0.271 times |
26 Tue Nov 2024 | 7.49 | 7.60 | 7.69 | 7.17 | 0.596 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Biocryst Pharmaceuticals (BCRX)
Date | Monthly Closing Price | Open | High | Low | Volume |
24 Tue Dec 2024 | 7.67 | 7.60 | 8.07 | 7.15 | 0.457 times |
26 Tue Nov 2024 | 7.49 | 8.03 | 8.44 | 6.85 | 1.426 times |
31 Thu Oct 2024 | 8.01 | 7.58 | 8.38 | 7.01 | 0.977 times |
30 Mon Sep 2024 | 7.60 | 8.61 | 8.88 | 7.48 | 0.68 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Biocryst Pharmaceuticals (BCRX)
Price action analysis of Biocryst Pharmaceuticals ( (BCRX) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Biocryst Pharmaceuticals ( (BCRX) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Biocryst Pharmaceuticals ( (BCRX) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Biocryst Pharmaceuticals ( (BCRX) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Biocryst Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Biocryst Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Biocryst Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a buy signal for Biocryst Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Biocryst Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 7.54 and Biocryst Pharmaceuticals (BCRX) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Biocryst Pharmaceuticals (BCRX) stock. Volume based technical analysis of Biocryst Pharmaceuticals (BCRX) stock is negative.
Biocryst Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Biocryst Pharmaceuticals ( (BCRX) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Biocryst Pharmaceuticals ( (BCRX) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Biocryst Pharmaceuticals ( (BCRX) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Biocryst Pharmaceuticals ( (BCRX) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Biocryst Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Biocryst Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Biocryst Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a buy signal for Biocryst Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Biocryst Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 7.54 and Biocryst Pharmaceuticals (BCRX) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Biocryst Pharmaceuticals (BCRX) stock. Volume based technical analysis of Biocryst Pharmaceuticals (BCRX) stock is negative.
Biocryst Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.